- Press Release -

Rockville, Md. Global sales of OTC analgesics are set to near US$ 25 Bn by 2022 on above-average growth, according to Fact.MR, as consumers lean on affordable, easy-to-buy pain relief. Demand for non-narcotic options in particular is climbing, driven by growing caution around the side effects of narcotic drugs.

North America leads by region, pharmacies remain the main channel, and tablets carry most of the volume. A steady shift toward online and modern trade is reshaping how these products reach buyers.

Channels, Forms and Regions

Pharmacies are the most lucrative channel, followed by drug stores and online outlets, but the quickest growth belongs to online and modern trade as shopping habits change. On form, tablets hold more than half of revenue and stay the format consumers prefer, while capsules rank second and post the highest growth rate.

North America holds the largest share and stays dominant, Europe ranks second, and Japan grows at a faster clip than Europe through the forecast period.

Convenience and Reform Drive Demand

The market runs on accessibility. Widely available OTC pain relievers make everyday symptom management simple, and rising use of off-label and non-narcotic drugs is broadening the ways consumers treat pain. Healthcare reforms and favourable regulation, together with pain management programs aimed at lowering overall care costs, are encouraging further uptake.

Suppliers and Their Playbook

The field brings together large pharmaceutical and consumer health companies.

• Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., GlaxoSmithKline Plc., Novartis AG, AstraZeneca Plc., Sun Pharmaceuticals Industries Limited, and Pfizer Inc. are among the key players in the report.

Reading the Market for Decisions

For manufacturers, growth favours non-narcotic lines and a stronger online presence. Investors get a market with dependable, self-care-led demand. Procurement and retail teams can plan around pharmacies leading sales, tablets carrying volume, and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global OTC analgesics market for the 2017 to 2022 forecast period, with segmentation by OTC channel, product form and region. It sizes each segment, maps the competitive field, and weighs the consumer forces shaping demand. Further detail is available in the OTC analgesics market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.